The cloning and characterization of a lyso-phosphatidic acid acyltransferase (LPAT2; EC 2.3.1.51) from Tropaeolum majus from a 20,000 EST collection is described. The 1358 bp TmLPAT2 gene encodes a 42.6 kD polypeptide; the primary sequence has a membrane bound O-acyltransferase, MBOAT, Box I motif, and Boxes II, III and IV typical of LPATs from various species. Unlike many LPAT2s, the gene was constitutively expressed in all tissues. The TmLPAT2 functionality was confirmed by expression in a yeast LPAT deletion (SLC1 -) mutant. The TmLPAT2 could use a range of acyl-CoAs as acyl donor, including 22:1-CoA and 20:1-CoA and either 18:1-LPA or 22:1-LPA as acyl acceptor. This new LPAT2 could enable the production of Brassica seed oils with enhanced levels of very long-chain fatty acids.
INTRODUCTION
Many groups worldwide have a vested interest in inserting genes into Brassica napus in an effort to produce the industrial feedstock trierucin. Erucic acid (cis-13 docosenoic acid, 22:1) is the major very long-chain fatty acid (VLCFA) in the seed oil from HEAR (high erucic acid rapeseed) B. napus cultivars, accounting for 45-55% of the total fatty acids [1] . HEAR cultivars are of high interest for industrial purposes because 22:1 is a valuable feedstock with more than 1000 potential or patented industrial applications [2, 3] . Currently the major derivative of erucic acid is erucamide, which is used as a surface-active additive in coatings and in the production of plastic films as an anti-block or slip promoting agent. Many other applications are foreseen for erucic acid and its hydrogenated derivative behenic acid, e.g. in lubricants, detergents, film processing agents and coatings, as well as in cosmetics and pharmaceuticals [4] [5] [6] [7] . For many of these industrial uses, the economics are limited by the proportion of 22:1 in the seed oil, approximately 45%. To compete with petroleum-based products, it is desirable to increase the 22:1 proportion as high as possible in order to reduce the cost of purification [3] . In addition, the engineering of HEAR Brassicaceae to produce seed oils containing substantial trierucin would lend the intact oil to a wide range of new applications [2] . In general, stereospecific analyses have shown that among most members of the Brassicaceae, 22:l is virtually excluded from the sn-2 position of TAGs [8] ; thus erucic acid is essentially found only in the sn-3 and the sn-1 positions, limiting the overall proportions of 22:1 to a maximum of about 66 mol %. The best HEAR B. napus spring cultivars have only about 55% erucic acid in the seed oil, but again, the proportion in the sn-2 position is negligible [7] .
In the traditional Kennedy pathway for seed oil (triacylglycerol, TAG) biosynthesis, lyso-phosphatidic acid acyltransferase (LPAT; EC 2.3.1.51) is the major enzyme responsible for acylating the sn-2 position of the glycerol backbone and therefore largely determines the sn-2 acyl composition of TAGs [9, 10] . This presumably ER-based LPAT is typically referred to as an LPAT2 in most oilseed species, distinguishing it from the plastidial LPAT1 which has enzyme characteristics more like the prokaryotic LPAT found in E. coli (See overview by Kim et al., [11] ).
Several studies have suggested that in B. napus the limitation with respect to erucic acid proportions at the sn-2 position is at least partially due to the inability of the LPAT2 to utilize erucoyl-CoA [12] [13] [14] [15] . Various groups worldwide have attempted or advocated the transformation of rapeseed with an LPAT2 gene which has the desired capacity to utilize erucoyl-CoA during TAG bioassembly [14] [15] [16] [17] [18] [19] . LPAT2s from Limnanthes spp appear to be capable of inserting erucoyl moieties into the sn-2 position. While the overall proportions of erucic acid in the seed oil of Limnanthes is only about 16%, of this, about 60% is found in the sn-2 position [14] [15] [16] [17] [18] [19] . Accordingly, LPAT2s from L. douglasii and L. alba have been cloned and used to enhance sn-2 erucic proportions in B napus [20] [21] [22] but with this single genetic modification, the enhancement of overall proportions of erucic acid and accumulation of significant trierucin have not resulted [23] . Indeed, the erucic acid was merely redistributed from the sn-1 and sn-3 positions to the sn-2 position, with no significant improvement in the mol % erucic acid in seed TAGs. This suggested, that in part, erucic acid supply was a limiting factor. Recently it has been shown that by combin-ing alleles of B. napus related to low polyunsaturated oils with the transgenic co-expression of the L. douglasii LPAT2 and over-expression of the BnFAE1 (encoding 3-ketoacylCoA synthase, catalyzing the first condensation reaction in the elongase complex which synthesizes erucic acid), a B. napus line with oil containing just over 70% erucic acid was obtained, clearly a breakthrough [24] .
The only species so far identified that naturally possesses erucic acid proportions of 75% or greater, mainly as trierucin, in its seed oil is garden nasturtium (Tropaeolum majus L.). Nasturtium is not an oilseed per se, accumulating only about 10-20% oil, but of this, 80-85% is trierucin. Thus, we chose T. majus as a model system for studying trierucin bioassembly so that this capacity could be engineered in a Brassica oilseed. It was in this context that we undertook the task of creating an EST collection of T. majus sequences in an effort to isolate and define specific genes which can contribute to trierucin synthesis. These nasturtium genes may provide a means to engineer rapeseed and other Brassica oilseeds to produce ultra-high erucic acid (80% or greater) oils. In our analysis of our 20,000-EST collection, we found two overlapping contigs which, when re-assembled, gave us a clone encoding a putative T. majus LPAT2 (TmLPAT2). We describe herein, its isolation and characterization by expression in a yeast LPAT -(slcΔ) deletion strain, and the implications for its utility in engineering new oilseed profiles.
MATERIALS AND METHODS

Plant Materials and Growth Conditions
Tropaeolum majus seeds (cultivar Dwarf Cherry Rose) were obtained from Early's Farm and Garden Centre, Saskatoon, SK, and were grown at the Kristjanson Biotechnology Complex greenhouses, Saskatoon, under natural light conditions supplemented with high-pressure sodium lamps with a 16 h photoperiod (16 h of light and 8 h of darkness) at 22ºC and a relative humidity of 25 to 30%. Flowers were handpollinated and seeds at various stages of development were harvested, their seed coats were removed and embryos were frozen in liquid nitrogen and stored at -80°C. The lipid composition of developing nasturtium embryos at various stages of development was determined. The following were the designated stages of embryo development in days post anthesis: Early: [25] .
Analysis of Oil Accumulation in Developing Tropaeolum majus Embryos
Freeze-dried T. majus embryos of early-, mid-and latedevelopmental stages, as well as mature seeds, were weighed and transferred to a cooled mortar and ground in 2 ml CH 2 Cl 2 :IPA (2:1). The mixture was transferred to a test tube to which was added the above solvent (1ml) and 0.9% NaCl (1ml) before vortexing; 2 ml CH 2 Cl 2 was added, the mixture re-vortexed and centrifuged at 2500 r.p.m. for 3 min. The CH 2 Cl 2 layer was removed, the extraction repeated and the CH 2 Cl 2 layers combined. CHCl 3 : Benzene: Methanol (1:1:1) (1ml) was added and then the sample evaporated to dryness. The dried sample was resuspended in CHCl 3 (1 ml) to give the total lipid extract (TLE). The developmental acyl composition of the TLE and the total oil content at each stage were determined by transesterification followed by GC using tri-15:0 as an internal standard and tri-17:0 as an external standard (to determine completeness of transmethylation) as described previously [25] . The T. majus TAG fraction was isolated by TLC and a stereospecific analysis performed as described by Taylor et al., [26] .
T. majus cDNA Library Construction and Normalization
cDNA was synthesized from mRNA isolated from middeveloping nasturtium embryos using a cDNA synthesis kit (Stratagene). The cDNA was directionally cloned into the pBluescript SK II (+) vector (Stratagene) and transformed into DH10B electrocompetent cells. The primary library was amplified using semi-solid agar (SeaPrep agarose, Mandel). Normalization of the library was performed at C 0 t 2.5 and C 0 t 5 following the normalization method 4 of Bonaldo et al., [27] . Double-stranded phagemid DNA was converted to single stranded DNA using Gene II protein and Exonuclease III (Genetrapper cDNA Positive Selection System, Gibco BRL, cat. no. 10356-020). The single stranded DNA was purified from the double stranded DNA using HAP chromatography (type II Hydroxyapatite, BioRad, cat. no. 158-4200). 20,000 ESTs from this library were sequenced as described below.
Sequencing and Analysis
Sequencing was performed on an ABI3730xl DNA Analyzer using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems). Sequence analyses were performed using Lasergene software (DNAStar, Madison, WI, USA). Sequence similarity searches and other analyses were performed using BLASTN, BLASTX [28] and PSORT [29] programs. The T. majus LPAT2 clone was represented by 2 overlapping contig members among 20,000 ESTs isolated and analyzed from a normalized cDNA library prepared from mid-developing nasturtium embryos.
Cloning of Full Length T majus (Tm) and A thaliana (At) LPAT2 cDNAs and Assembly of Yeast Transformation Constructs
TmLPAT2
Primers were designed to amplify the TmLPAT2 gene with adaptor restrictions sites (in italics): 5' primer amplifying TmLPAT2 sequence with a Kpn I restriction site (GAGGTACCGGAAATGTCAGTTGCAGC); 3' primer amplifying TmLPAT2 sequence (+ stop codon) with an Xho I site (CCGCTCGAGTTTTACTGATGTTTGGTTGC). cDNA was synthesized from total RNA extracted from T. majus mid-developing embryos using Superscript II (Invitrogen). The TmLPAT2 gene was amplified from the cDNA using Turbo Pfu polymerase (Stratagene) on a RoboCycler thermocycler (Stratagene) using the following program: 95°C for 3 min, followed by 30 cycles of 95°C for 30 sec, 55°C for 45 sec, 72°C for 2 min, an additional extension of 72°C for 10 min was included. The amplified PCR product was digested using restriction enzymes KpnI (NEB) and XhoI (NEB). The PCR-amplified TmLPAT2 was directionally cloned into the respective KpnI and XhoI sites of pYES/NT B (Invitrogen) using T4 DNA ligase (Invitrogen) in a 4:1 molar ratio (insert: vector) at 4°C overnight. Four microliters of the ligation reaction were used to transform Top10 Chemically Competent Cells (Invitrogen) as per standard protocols. Putative clones were cultured in liquid medium with ampicillin selection, and grown overnight at 37°C with shaking (250 rpm). Plasmid DNA was extracted using a QIAprep Spin miniprep kit (Qiagen). PCR screening for the gene insert was performed using GAL1/V5CR primers and Taq polymerase (Program: 95° -3 min; 30 cycles of 95°C -30s, 52°C -45s, 72°C-2 min; 72°C-10 min). Positive clones were confirmed by sequencing.
At LPAT2
Primers were designed to amplify the A. thal LPAT2 gene (Accession No. At3g57650) with adaptor restrictions sites (in italics): 5' primer amplifying AtLPAT2 sequence with a Kpn I restriction site (CCGGTACCAGGATGGTGATTGC-TGCAGCT); 3' primer amplifying AtLPAT2 sequence (+ stop codon) with an Xho I site CCCTCGAGTGTGAGAAC-CAGTTTTTACTT). Total RNA was extracted from A. thaliana ecotype Columbia leaves using Trizol (Invitrogen) and the cDNA was synthesized and used to amplify the A thaliana LPAT2 as described for the TmLPAT2 above.
Molecular Analyses of the TmLPAT2
The alignment of the TmLPAT2 with other cloned LPATs shown in For Southern analysis, total DNA was extracted from 1 g of T. majus leaves according to Dellaporta et al., [30] . About 15 ug of genomic DNA were digested with restriction enzymes AseI, EcoRI, HindIII and XhoI (NEB) and the fragments separated by agarose gel (0.7%) electrophoresis in 1X TAE buffer. The DNA was blotted onto Amersham Hybond XL (GE Healthcare) membrane using a Turbo Blotter (Whatman) and following the alkaline transfer procedure (0.4 N NaOH). The Southern probe was amplified by PCR with primers designed to bind to a 450 bp region from the 5′end of the KCS gene and that would not be cut by the restriction enzymes selected here. Hybridization was carried out in Denhardt's buffer at 65 0 C for 16 h using the 32 P-labeled DNA probe using a Random Primers labeling kit (Invitrogen). High stringency washings were performed at 65 o C (2X 15 min with 2X SSC/0.1 % SDS and 1X 15 min with 0.1 X SSC/0.1 % SDS) before exposing to X-ray film (Fuji Medical X-Ray film) at -80 0 C.
In studies of TmLPAT2 expression by northern analysis, total RNA was extracted using either Trizol Reagent (Invitrogen) for root, stem and leaf tissues, or using the method of Wang and Vodkin [31] for flower and embryonic (three developmental stages) tissues. 20 µg of each sample were loaded onto a 1.2 % denaturing formaldehyde agarose gel. The RNA was transferred onto a Nytran SuPerCharge membrane in 10 X SSC using a Turbo Blotter (Whatman) and hybridized as above using a full length TmLPAT cDNA as a probe. High stringency washings were performed at 60 0 C, 2X 15 min with 40 mM NaPO4/1 mM Na EDTA/0.5 % SDS and 2X 15 min with 40 mM NaPO4/1 mM Na EDTA/0.1 % SDS before exposing to X-rays at -80 0 C.
Transformation of Y03749 Yeast LPAT -Deletion Mutant Strain with TmLPAT2 or AtLPAT2
Yeast strain Y03749 (slc1Δ, MATα his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 YDL052c::KanMX4) was transformed with the pYES2 NT B-AtLPAT2 or with pYES2 NT B-TmLPAT2 or with empty pYES2 NT B vector using the small scale yeast transformation method from the pYES2 NT B manual. Clones were selected on plates contaning (SC -Uracil + 2% Glucose).
Transformation was confirmed as follows: DNA from putative positive clones was extracted using a quick plasmid extraction method. A single colony was picked into 200 µl lysis buffer (100mM NaCl, 10mM Tris-HCL pH8.0, 1mM EDTA, and 0.1% SDS). An equal volume of acid-washed beads (0.5mm diameter) was added along with 200 µl phenol:choloroform (2:1), the sample vortexed for 30 seconds, followed by slow rotation for 5 minutes to complete the extraction. The mixture was then centrifuged for 5 minutes at 13000 rpm. The aqueous phase was recovered and the DNA precipitated using 2 volumes of ethanol and 0.1 x volume of 3M sodium acetate. The sample was incubated at -80°C for 30 minutes then centrifuged at 13000 rpm for 15 min. The DNA pellet was washed with 80% ethanol, re-centrifuged at 13,000 rpm for 5 min, the DNA pellet air dried and resuspended in 50 µl TE buffer. DNA concentration was measured using a NanoDrop ND-1000 spectrophotometer. Top10 Chemically Competent cells (Invitrogen) were transformed with the purified DNA as per a standard protocol. Colonies were screened by PCR and restriction digests.
TmLPAT2 and AtLPAT2 Expression in Y03749 Yeast
LPAT -(slcΔ) Deletion Mutant and Assay of LPAT Activity
Starter cultures of the Y03749 TmLPAT2, Y03749 AtL-PAT2 or Y03749 plasmid only (control) transformants were grown in minimal medium (SC -Uracil + 2% Glucose) at 30°C with shaking at 250 rpm. Culture density was measured using OD 595 , and sufficient culture to produce an OD 595 =0.4 in 50ml of Induction Medium (SC -Uracil + 2% Galactose + 1% Raffinose) was centrifuged, washed and resuspended in Induction Medium. Cultures were induced at 30°C with shaking (250 rpm) for 8, 16, 24 or 48 hrs. The maximum expression of the TmLPAT2 recombinant protein was obtained after a 24 hour induction; the AtLPAT2 expression was maximal at 48 hr of induction. Induced cells were harvested by centrifugation and protein was extracted using the glass bead/bead beater method. Protein concentration was measured in triplicate using Bradford reagent, normalized and the protein was used immediately for the LPAT assay.
LPAT assays of the recombinant protein fraction from each transformant were conducted as described previously [26] using either 14 C 18:1-CoA or 14 C 22:1-CoA as the acyl donor and 18:1-LPA or 22:1-LPA as the acyl acceptor. The resolution of the 14 C-labeled PA product by TLC run in ethyl acetate/iso-octane/acetic acid (45/15/10) was as described by Taylor et al. [26] .
LPCAT assays of the recombinant protein fraction from each transformant were conducted using 14 C 18:1-CoA or 14 C 22:1-CoA as the acyl donor and 18:1-LPC as the acyl acceptor according to the method described by Stahl et al. [38] .
RESULTS AND DISCUSSION
Oil and Erucic Acid Accumulation in Developing T. majus Embryos
We assumed that, like other Kennedy pathway enzymes (e.g. T. majus DGAT1 which we cloned and characterized previously [32] ), the LPAT2 would also be at its highest expression and activity at the mid-point of the exponential phase of embryo growth. For nasturtium, the peak of oil deposition (about 16% oil as % of DW) and the maximal erucic acid proportion therein (about 78% wt/wt), occurred in the mid-late developmental stage, typically 20-26 days post-anthesis (Fig. 1) . This was the embryo stage harvested and stored at -80°C for molecular and analytical work.
A stereospecific analysis of the T. majus TAG fraction revealed that the erucic acid was distributed about equally among the three sn-positions on the glycerol backbone ( Table 1) . This suggested a strong capacity to esterify erucic acid at the sn-2 position and implied that enzymes like LPAT or LPCAT may be involved.
Analysis of the TmLPAT2 Gene
Upon sequencing and analysis of our 20,000 T. majus ESTs, we found 2 overlapping contigs, which when assembled, gave a sequence which encoded a putative TmLPAT2 gene. The TmLPAT2 gene and protein sequences were deposited in GenBank (Accession No. FJ984563). The consensus TmLPAT2 nucleotide sequence of 1358 bp encodes a protein of 380 amino acids and has a predicted molecular mass of 42.585 kD, and a pI of 9.60. Based on a KyteDoolittle analysis using the Protean suite of DNAStar, there appear to be at least 8 transmembrane regions and a hydrophilicity pattern which is globally-shared among the LPAT2s from B. napus, B. oleracea, A. thaliana, Crambe, Prunus and Limnanthes (data not shown).
Alignment and phylogenetic tree assessment of the TmLPAT2 and its most homologous relatives are shown in a >95% of total GC FAME peaks accounted for in all cases. b tr = < 0.05% wt/wt; minor traces of other fatty acyl moieties not shown. 
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F P P P P R F P P R F P P R F P P R F P P F P P Box II is a LPVIGW motif, Box III is a "EGT" box, Box IV is a NVLIPRTKGF motif, and the final box with an arrow is a putative tyrosine phosphorylation site R 215 -(X) 6 -Y 222 -(X) 4 -A 227 , which is a characteristic motif consisting of an arginine at position -7, tyrosine at position 0, and glycine/alanine at position +5 [34] . The sequence FVEGTR(F/S) is conserved among these plant LPAT2s as well as the E. coli LPAT (plsC; [35, 36] and the Saccharomyces cerevisiae LPAT (SLC1; [37] ). Among more than half the dozen plant LPAT2s depicted in the phenogram in Fig. (3) , the TmLPAT2 showed high homologies (74%-79%). The TmLPAT2's closest homolog was to a LPAT from Prunus mume (79.5%, GenBank accession number BAE48660). High identity was observed with LPAT2s from Limnanthes douglassii (75.6%, GenBank accession number CAA88620), Crambe hispanica (75.3%, GenBank accession number ABN09946), B. napus (75.3%, GenBank accession number Q9XFW4), A. thaliana (74.7%, GenBank accession number NM_115625), and B. oleracea (74.8%, GenBank accession number Q6IWY1). It is interesting that the closest homolog, P. mume, has kernel oil containing only oleic (58-74%), linoleic (20-34%) and palmitic (4-7%) acids, but virtually no VLCFAs (http:// www.woodlandnut.com/apricot.html).
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Southern analyses, using restriction enzymes that do not cut within the region recognized by the probe and high stringency washings, resulted in a simple banding pattern with one single band of high intensity suggesting that there is only one copy of the LPAT2 gene in the nasturtium genome (Fig. 4A) .
Northern analyses (Fig. 4B) showed that the gene was expressed in all tissues tested, including roots, stems, leaves, flowers, and at all three developmental embryo stages tested (with the mid-developing stage having the strongest embryo expression). While unusual, this ubiquitous, constitutive expression pattern is similar to that reported previously [11] for an ER-based LPAT2 essential for female but not male, gametophyte development in Arabidopsis. However, the current pattern is distinct from Limnanthes which is known to have both an embryo-specific LPAT2 gene and a constitutivelyexpressed LPAT1 [20] . Indeed, most LPAT2s utilizing unusual fatty acids are seed-specific [10] . The current finding represents, to our knowledge, the first oilseed LPAT2 utilizing unusual fatty acids that is expressed ubiquitously, with expression levels even higher in vegetative tissues, than in developing seed. The vegetative tissues do not synthesize or accumulate erucic acid, so this suggests that the TmLPAT2 enzyme is promiscuous and accepts a wide range of acyl groups. . (3) . Phylogenetic tree comparing the LPAT2s cited in Fig. (2) . The TmLPAT2 heterologously expressed in the yeast SLC1 -mutant was able to incorporate 22:1 into the sn-2 position of 18:1-LPA from 22:1-CoA (Fig. 5) . In following the induction of gene expression (8, 16, 24 , 48 hr; data not shown), the strongest expression was observed after 24 hours of induction. In fact, in the presence of 18:1-LPA as an acceptor, the heterologously-expressed TmLPAT2 was able to utilize a range of acyl-CoA substrates (Fig. 6A) including 16:0-CoA, 18:1-CoA or 20:1-CoA, with about equal efficiency. Erucoyl-CoA was also a capable acyl donor, with the activity being about 55% of that observed with oleoyl-CoA. This relative acyl preference profile for the recombinant TmLPAT2 is similar to that reported by Brough et al., [20] using recombinant L. douglasii LPAT2 expressed in an E. coli LPAT -mutant strain JC201; in that study, the L douglasii LPAT2 22:1-CoA activity was approx 30% of that observed with oleoyl-CoA. The TmLPAT2 was also able to use 22:1-LPA as an acceptor in the presence of either 18:1-CoA or 22:1-CoA as the acyl donor; the 22:1-CoA LPAT activity with 22:1-LPA was about 20% of that observed with the 18:1-CoA donor (Fig. 6B) . In vivo upon biosynthesis of oil in developing nasturtium seeds, trierucin is the major prod- In contrast, while the heterologously-expressed AtLPAT2 was able to use oleoyl-CoA, it was unable to use erucoylCoA significantly, a trend identical to that observed with a B. napus Topas LPAT2 positive control system wherein erucoyl-LPAT activity was less than 2% of oleoyl-LPAT activity. This trend also agrees with our past biochemical studies [26] . In comparing the TmLPAT2 and AtLPAT2 activities at maximal heterologous expression in yeast, the specific activity of the expressed TmLPAT2 with oleoyl-CoA + 18:1-LPA as substrates was approximately 4-fold higher than the corresponding activity with AtLPAT2 (Fig. 6C) . The reason for this markedly higher activity of the TmLPAT2 is currently unclear, but may point to the preference for genetically over-expressing the TmLPAT2 to enhance flux through the Kennedy pathway and into oil. Such experiments have been successful with the yeast SLC1-1 mutated LPAT gene [44] .
While there has recently been another lyso-phospholipid acyltransferase discovered in yeast (ScLPLAT), it differs from the specific lyso-phosphatidic acid acyltransferase that is encoded by SLC1 in that it cannot efficiently use lysophosphatidic acid produced by acylation of glycerol-3-phosphate in vitro; rather, it prefers to acylate lysophosphatidylcholine (LPC) [38] . Under our assay conditions, in the control Y03749 LPAT -mutant transformed with empty plasmid, wherein the ScLPLAT activity is still present, there was low but significant LPLAT activity with (Fig. 6D) . Neither was there acylating activity observed when LPE, LPS or LPI were provided as acyl acceptors (data not shown). This clearly confirms that the T. majus erucoylCoA:LPAT activity expressed in the Y03749 LPAT -mutant background is not due to the ScLPLAT.
Our findings indicate that the cloned and ectopicallyexpressed TmLPAT2 gene encodes a product which can utilize a number of acyl-CoA donors to acylate the sn-2 position of LPA, including erucoyl-CoA, at a rate of the same order of magnitude as that observed with oleoyl-CoA. The TmLPAT2 is not highly acyl-CoA-specific.
Predictions of acyl specificity of LPATs have arisen primarily from biochemical studies involving LPAT enzyme assays of microsomal fractions from developing seeds. Previous studies of the LPATs from a number of oilseeds had suggested that the TmLPAT was not involved in synthesis of trierucin because microsomal preparations from developing T. majus embryos exhibited little or no LPAT activity with erucoyl-CoA [16, 39] . In contrast, our in vitro study showed that activity of erucoyl-CoA LPAT was present in developing nasturtium embryos [26] . However, short of cloning and expressing a candidate gene, biochemical evidence can be misleading as to how it will perform in vivo: Case in point, we ourselves reported, based on microsomal LPAT enzyme assays of a high erucic B. oleracea landrace, that the LPAT could utilize erucoyl-CoA in vitro, [26] . However, its capacity to do so in vivo proved negative once we cloned the gene and into the sn-2 position of TAGs was nil (Taylor et al., 2005, unpublished) .
Highly homologous predicted protein sequences can encode members of the same family of enzymes which nonetheless have widely varying catalytic substrate specificities not apparent from their primary sequences or even based on in vitro biochemical analyses. Indeed, of the LPAT2s listed in Fig. 3 using homology algorithms, until the present study, only those from Limnanthes spp have been shown to possess erucoyl-CoA LPAT activity [21] . Yet the homology scores are very close: For example, the L. douglasii sequence is known to be an erucoyl-utilizing LPAT2 while the albeit homologous B. napus and Arabidopsis LPAT2 sequences at 75% identity, do not encode enzymes with any capacity to utilize erucoyl moieties; the T. majus LPAT2 is negligibly more homologous to the Limnanthes LPAT2 at 75.6% identity than it is to the B. napus LPAT2 at 75.3% identity. Thus, the selective characteristics of the T. majus and Limnanthes LPAT protein sequences that lead to erucoyl-CoA-utilizing capability are not currently understood. However, now having a second LPAT (T. majus) with this capability will provide an opportunity for more detailed comparative studies of 
CONCLUSIONS
In summary, our findings would suggest that TmLPAT2 does indeed possess a strong capacity to utilize 22:l-CoA. Combined with other studies of the biosynthesis of TAGs containing sn-2 22:l in T. majus [40] [41] [42] , it appears that such TAGs are probably synthesized via the Kennedy pathway and not via acyl exchange at the sn-2 position of DAGs and TAGs as suggested previously [39] . Thus, in all oilseeds studied thus far that accumulate TAGs containing VLCMFAs, the data are consistent with VLCMFA biosynthesis by elongation of oleoyl moieties to give VLCMFACoAs, which are then used in the synthesis of TAGs via the Kennedy pathway acyltransferases.
We propose that the capacity to acylate the glycerol backbone with erucoyl moieties at the sn-2 position, is a very valuable property for molecular breeding of high erucic acid plants. For example, the expression of the TmLPAT2 clone in high erucic Brassicaceae (e.g. the high erucic B. carinata lines co-expressing the Crambe KCS and an RNAi-silenced B. carinata FAD 2 [43] or the Cardamine graeca KCS [45] , will be capable of enhancing the overall proportions of VLCFAs in the sn-2 position of TAGs and increase the probablility of producing trierucin or trinervonin, respectively. In addition, the transgenic over-expression of the TmLPAT2 in the Brassicaceae may afford improvements in oil content in a manner not dissimilar to that already shown for ectopic expression of the yeast SLC1-1 gene [44] ). Accordingly, transformation experiments are currently underway in our lab to test these hypotheses. 50151. 
